SECsense Logo

SpringWorks Therapeutics 8-K Report: Key Financial Insights as of January 2025

$SWTX
Form 8-K
Filed on: 2025-01-13
Source
SpringWorks Therapeutics 8-K Report: Key Financial Insights as of January 2025

Based on the provided section of the financial report, here are the key insights:

  1. Entity Overview:
  • Name: SpringWorks Therapeutics, Inc.
  • State of Incorporation: Delaware (DE).
  • CIK: 0001773427.
  • SEC File Number: 001-39044.
  • EIN: 83-4066827.
  • Address: 100 Washington Blvd, Stamford, CT 06902.
  • Phone: 203-883-9490.
  1. Filing Information:
  • Filing Type: 8-K (Current Report).
  • Filing Date: January 13, 2025.
  1. Stock Information:
  • Common Stock: The company has common stock with a par value of $0.0001 per share.
  • Ticker Symbol: SWTX.
  • Exchange: NASDAQ.
  1. Financial Reporting Context:
  • Report Date: The report is as of January 13, 2025.
  • Unit of Measurement: Financial figures are reported in U.S. Dollars (USD) and shares.
  1. XBRL Schema Reference:
  • The report references an XBRL schema file named "swtx-20250113.xsd", indicating that the data is formatted for machine-readable financial reporting.

These points provide a concise summary of the essential details from the financial report section, reflecting the company's identity, filing specifics, and stock-related data.